Greg Sebepos-Rogers
@gseberog.bsky.social
📤 195
📥 121
📝 1
Gastroenterologist @Imperial, organoid dabbler, interested in Inflammatory Bowel Disease.
reposted by
Greg Sebepos-Rogers
Kevin Monahan
7 days ago
Our results support universal and paired somatic and germline multi-gene panels for all EOCRC patients, regardless of MMR status or family history
onlinelibrary.wiley.com/doi/10.1002/...
loading . . .
https://onlinelibrary.wiley.com/doi/10.1002/ueg2.70112
0
1
3
reposted by
Greg Sebepos-Rogers
Joram Mooiweer
3 months ago
www.sciencedirect.com/science/arti...
loading . . .
Co-development of mesoderm and endoderm enables organotypic vascularization in lung and gut organoids
The vasculature and mesenchyme exhibit distinct organ-specific characteristics adapted to local physiological needs, shaped by microenvironmental and …
https://www.sciencedirect.com/science/article/abs/pii/S0092867425006282?dgcid=coauthor
0
1
1
reposted by
Greg Sebepos-Rogers
Ben Mullish
5 months ago
Honoured to to be part of this Future of Hepatology session at
@easlnews.bsky.social
#EASL2025
, discussing the promise of
#microbiome
related therapies in
#PSC
#cholestatic
liver disease - where have we come since the original
#FMT
#PSC
pilot study by @DrAllegrettiIBD?
doi.org/10.14309/ajg...
2
8
3
reposted by
Greg Sebepos-Rogers
Omid S. Alavijeh
6 months ago
📘 What could nephrology look like in 2050? This article for the Future Healthcare Journal was fun to write! — here’s a 🧵 of what might be coming next in kidney care:
shorturl.at/A18zK
loading . . .
The future of nephrology in 2050
As medicine advances at an unprecedented pace, the field of nephrology is poised for transformative change. By 2050, breakthroughs in kidney disease p…
https://shorturl.at/A18zK
1
6
5
reposted by
Greg Sebepos-Rogers
Kevin Monahan
7 months ago
The National Genomics Education Programme have launched
#GeNotes
collection specifically for
#Genomics
cases in your practice
@britsocgastro.bsky.social
www.bsg.org.uk/news/new-nat...
loading . . .
New national genomics resources in Gastroenterology and Hepatology
The National Genomics Education Programme have launched #GeNotes collection specifically for #Genomics cases in your practice. It is packed with educational scenarios written by experts in your field,...
https://www.bsg.org.uk/news/new-national-genomics-resources
1
5
4
reposted by
Greg Sebepos-Rogers
George Monbiot
7 months ago
1. You feel powerless? Don’t know what you can do to resist the rise of fascism? Here is an answer: Good Things. Fascism inflicts pain and harm as a matter of doctrine. Kindness, care and conviviality defend us from it. The more we build community, the less it can take root. 🧵
81
2872
1120
reposted by
Greg Sebepos-Rogers
Ben Mullish
7 months ago
A great first day at the
#BSG
#GutMicrobiome
event, covering everything from early life
@halllab.bsky.social
, to
#liver
@debbieshawcross.bsky.social
, to
#cancer
@jameskinross.bsky.social
, and culminating in a tour de force on
#IBD
and the
#microbiome
in clinical practice from Prof Harry Sokol
1
7
1
reposted by
Greg Sebepos-Rogers
MRC Laboratory of Medical Sciences
8 months ago
🚨 We're hiring! 🚨 The Chain Florey Transition-To-Independence Fellowship Scheme is open for applications! We have 3 positions available: 2 generic and 1 cardiology specific. If you're a clinician scientist this is your chance to join the Chain Florey program! Don't miss out—apply now! 💼👇
loading . . .
Vacancies at the LMS
View all the current vacancies at the MRC Laboratory of Medical Sciences, including research, technician, and support roles and jobs.
https://lms.mrc.ac.uk/work-and-study/vacancies/
0
5
2
reposted by
Greg Sebepos-Rogers
IBD Doctor
8 months ago
Wondering if your patient with small bowel inflammation has Crohn's vs intestinal TB? Summarize all of your data with this website to get a probability. Add new (projected) test results to see how new results would change the estimate.
#IBD
www.pathology.med.umich.edu/shiny/tbcroh...
loading . . .
Model to differentiate intestinal TB from Crohn's disease
https://www.pathology.med.umich.edu/shiny/tbcrohns/
0
5
2
reposted by
Greg Sebepos-Rogers
Jennie Clough
9 months ago
Really enjoyed working on this review for Frontline Gastroenterology. How do anti-IL23 therapies work? What’s the evidence for their use in IBD? And is there any guidance on how we should position them in the treatment landscape?
fg.bmj.com/content/earl...
0
7
2
reposted by
Greg Sebepos-Rogers
Ben Mullish
9 months ago
Pleased that
#FARGO
- a randomised, multicentre, placebo-controlled phase IIa trial of
#FMT
to treat
#PSC
- is running and recruiting. Have a look at the protocol paper out now in
#BMJOpen
:
doi.org/10.1136/bmjo...
@pscsupport.bsky.social
@cholestasisdoc.bsky.social
loading . . .
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial
Introduction Primary sclerosing cholangitis (PSC) is the classical hepatobiliary manifestation of inflammatory bowel disease (IBD). The strong association between gut and liver inflammation has driven...
https://doi.org/10.1136/bmjopen-2024-095392
1
23
12
reposted by
Greg Sebepos-Rogers
Waggoner Lab
10 months ago
Intestinal E. coli-produced yersiniabactin promotes profibrotic macrophages in Crohn’s disease
www.cell.com/cell-host-mi...
0
12
2
reposted by
Greg Sebepos-Rogers
Wiebke Arlt
10 months ago
Check out the
@mrc-lms.bsky.social
Chain Florey clinician scientist programme for those interested in mechanistic discovery science and experimental medicine - 12-month predoctoral fellowships currently up for grabs!
lms.mrc.ac.uk/work-and-stu...
add a skeleton here at some point
0
14
5
reposted by
Greg Sebepos-Rogers
The Francis Crick Institute
10 months ago
What is inflammatory bowel disease (IBD) and how can a gene desert help us to understand its causes and potential future treatments? 🧬🧪 Hear the Crick's James Lee sharing his insights in the first in our series of Crick Crash Courses.
www.youtube.com/watch?v=bcc8...
loading . . .
IBD and Gene Deserts - with James Lee
YouTube video by Francis Crick Institute
https://www.youtube.com/watch?v=bcc8yv1VlUo
0
32
10
reposted by
Greg Sebepos-Rogers
Snippert lab
10 months ago
New work on
#tuft
cells, rare guardians of our
#gut
against invaders. How they work is not known. We show that intestinal tuft types 1&2 are sequentially expressed phenotypes during differentiation. And…we can now generate mature immune-related tuft-2’s in
#organoids
for more 🔬🧫🧬🔥
shorturl.at/EImjA
loading . . .
Mature tuft cell phenotypes are sequentially expressed along the intestinal crypt-villus axis following cytokine-induced tuft cell hyperplasia
Intestinal tuft cells are epithelial sentinels that trigger host defense upon detection of parasite-derived compounds. While representing interesting targets for immunomodulatory therapies in inflamma...
https://shorturl.at/EImjA
1
29
12
reposted by
Greg Sebepos-Rogers
Mike Schumacher
10 months ago
We know everything about IL-33 already, right? No! In fact we know very little about IL-33 in the colonic epithelium Our recent paper finds IL-33 is highly enriched in colonic stem cells suggesting an immunoregulatory role for this niche in injury🧵
www.mucosalimmunology.org/article/S193...
2
31
7
reposted by
Greg Sebepos-Rogers
Ivan Zanoni
10 months ago
#LocationLocationLocation
! Baghdadi, Kim &co show
@science.org
that intestinal stem cells
#ISCs
located at the bottom of the crypts sense a more rigid environment & activate PIEZO to tune their proliferation/differentiation maintaining gut physiology!
doi.org/10.1126/scie...
loading . . .
PIEZO-dependent mechanosensing is essential for intestinal stem cell fate decision and maintenance
Stem cells perceive and respond to biochemical and physical signals to maintain homeostasis. Yet, it remains unclear how stem cells sense mechanical signals from their niche in vivo. In this work, we ...
https://doi.org/10.1126/science.adj7615
1
28
10
reposted by
Greg Sebepos-Rogers
Aydan Szeto
10 months ago
#immunosky
The power of spatial information! ILC2s specifically in the middle of the colon express microbiota-induced genes that are important for the structural adaptation of this part of the gut. Loads of spatial data across different states (homeostasis vs inflammation) for the community.
loading . . .
https://www.nature.com/articles/s41586-024-08216-z
https://t.co/9IXkMinzri
1
20
2
reposted by
Greg Sebepos-Rogers
Achille Broggi🧪👨🏼🔬🔬
11 months ago
👨🔬🎉Kicking off my bluesky presence by posting our lab's achievement! Our lab's first study is now out in Cell ! We show that IFN-λ induces ZBP1/CASP-8/GSDMC-dependent pyroptosis in gut epithelial cells impairing tissue repair post-colitis.#IBD
#Immunology
🧵https://authors.elsevier.com/a/1k2OAL7PXqSL5
17
254
22
reposted by
Greg Sebepos-Rogers
Veronika Horn
11 months ago
Happy to share the work from my residency at
#Charite
available as pre-proof version in
#Gastroenterology
. We identify Ki67+ memory CD4+ T cells as robust blood-based predictor for non-response to
#vedolizumab
(anti-integrin a4b7) in
#IBD
patients before therapy.
doi.org/10.1053/j.ga...
loading . . .
Redirecting
https://doi.org/10.1053/j.gastro.2024.09.021
1
8
2
reposted by
Greg Sebepos-Rogers
Lionel Le Bourhis
11 months ago
Very proud of this one. Sarah Hamoudi, PhD student in the lab, developed autologous cocultures between mucosal T cells and epithelial organoids from control or from patients with Crohn's disease.
www.biorxiv.org/content/10.1...
loading . . .
T cell mediated impairment of epithelial integrity in Crohn's disease
T lymphocytes play a major role in intestinal homeostasis, with a particular impact on the balance between self-renewal and differentiation of intestinal epithelial cells (IECs). In Crohn's disease (C...
https://www.biorxiv.org/content/10.1101/2024.11.12.621219v1
2
25
11
you reached the end!!
feeds!
log in